Masimo (NSDQ:MASI) yesterday revealed an unspecified investment in Germany’s TNI Medical and its respiratory aid technology.
Würzburg-based TNI developed the SoftFlow technology to deliver high-flow, warmed and humidified respiratory gases to pulmonary disease patients. It’s designed to provide room air or a mix of room air and oxygen without pneumatic systems, Masimo said.
“The innovative products TNI has developed provide clinicians with important additional tools to address the growing number of people affected by pulmonary diseases,” Masimo founder, chairman & CEO Joe Kiani said in prepared remarks. “We are happy to provide TNI with an investment that will allow the company to continue to commercialize its products in the large and fast growing high-flow nasal therapy market.”